Lorusso D - Search Results

1

Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.

Ferrandina G, Paris I, Ludovisi M, D'Agostino G, Testa A, Lorusso D, Zanghi M, Pisconti S, Pezzella G, Adamo V, Breda E, Scambia G. Ferrandina G, et al. Among authors: d agostino g, lorusso d. Gynecol Oncol. 2005 Aug;98(2):267-73. doi: 10.1016/j.ygyno.2005.04.018. Gynecol Oncol. 2005. PMID: 15975643 Clinical Trial.

2

Gemcitabine is ineffective in recurrent, preirradiated cervical cancer.

Greggi S, D'Agostino G, Smaniotto D, Genovesi D, Lorusso D, Scambia G. Greggi S, et al. Among authors: d agostino g, lorusso d. Gynecol Oncol. 2000 Jul;78(1):76-7. doi: 10.1006/gyno.2000.5817. Gynecol Oncol. 2000. PMID: 10873416 Clinical Trial. No abstract available.

3

Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer.

Greggi S, Salerno MG, D'Agostino G, Ferrandina G, Lorusso D, Manzione L, Mancuso S, Scambia G. Greggi S, et al. Among authors: d agostino g, lorusso d. Oncology. 2001;60(1):19-23. doi: 10.1159/000055291. Oncology. 2001. PMID: 11150903 Clinical Trial.

4

Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer.

D'Agostino G, Ferrandina G, Garganese G, Salerno MG, Lorusso D, Farnetano MG, Mancuso S, Scambia G. D'Agostino G, et al. Among authors: lorusso d. Oncology. 2002;62(2):110-4. doi: 10.1159/000048255. Oncology. 2002. PMID: 11914595 Clinical Trial.

5

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

Lorusso D, Ferrandina G, Greggi S, Gadducci A, Pignata S, Tateo S, Biamonte R, Manzione L, Di Vagno G, Ferrau' F, Scambia G; Multicenter Italian Trials in Ovarian Cancer invesitgators. Lorusso D, et al. Ann Oncol. 2003 Jul;14(7):1086-93. doi: 10.1093/annonc/mdg301. Ann Oncol. 2003. PMID: 12853351 Free article. Clinical Trial.

6

Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer.

D'Agostino G, Ferrandina G, Ludovisi M, Testa A, Lorusso D, Gbaguidi N, Breda E, Mancuso S, Scambia G. D'Agostino G, et al. Among authors: lorusso d. Br J Cancer. 2003 Oct 6;89(7):1180-4. doi: 10.1038/sj.bjc.6601284. Br J Cancer. 2003. PMID: 14520442 Free PMC article. Clinical Trial.

7

Angiographic power 3-dimensional quantitative analysis in gynecologic solid tumors: feasibility and reproducibility.

Testa AC, Mansueto D, Lorusso D, Fruscella E, Basso D, Scambia G, Ferrandina G. Testa AC, et al. Among authors: lorusso d. J Ultrasound Med. 2004 Jun;23(6):821-8. doi: 10.7863/jum.2004.23.6.821. J Ultrasound Med. 2004. PMID: 15244306

8

Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile?

Lorusso D, Naldini A, Testa A, D'Agostino G, Scambia G, Ferrandina G. Lorusso D, et al. Among authors: d agostino g. Oncology. 2004;67(3-4):243-9. doi: 10.1159/000081324. Oncology. 2004. PMID: 15557785 Clinical Trial.

9

Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer.

Lorusso D, Ferrandina G, Lo Voi R, Fagotti A, Scambia G. Lorusso D, et al. J Chemother. 2004 Nov;16 Suppl 4:98-103. doi: 10.1179/joc.2004.16.Supplement-1.98. J Chemother. 2004. PMID: 15688622 Review.

10

Pegylated liposomal doxorubicin in platinum-treated recurrent or metastatic cervical carcinoma.

Ferrandina G, Lorusso D, Longo R, Testa AC, Scambia G. Ferrandina G, et al. Among authors: lorusso d. Gynecol Oncol. 2005 Aug;98(2):332-3. doi: 10.1016/j.ygyno.2005.04.008. Gynecol Oncol. 2005. PMID: 15907985 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters